Zachary Brennan

Back in January, Takeda won approval for a new indication for its primary immunodeficiency drug HyQvia, this time as a treatment for a rare autoimmune …

The first round of negotiations under the Inflation Reduction Act will save Medicare $6 billion in 2026, the Biden administration announced Thursday.

For the first 10 drug prices negotiated under the Inflation Reduction Act, about one-half of the estimated $6 billion in Medicare savings is the result …

In an update to a warning issued last year, the FDA said Wednesday it remains concerned about the risk of aluminum toxicity associated with a …

The FDA on Thursday issued an order denying Intarcia's appeal over its rejected type 2 diabetes combo product, ending nearly eight years of back-and-forth on …

The FDA initially rejected nearly half of all biologics applications received last year, many for quality-related CMC issues that need to be improved upon, according …

House Oversight Chair James Comer (R-KY) has told the CEOs of the three major PBMs — CVS Caremark, Express Scripts and Optum Rx — to correct what …

Ipsen Pharmaceuticals sold its priority review voucher to an unidentified “large global pharmaceutical company” for $158 million, it said this week, the highest publicly announced …

Johnson & Johnson paid $3.4 billion upfront for the surgical robotics company Auris Health in 2019, with the potential for $2.35 billion more in commercial …

Peter Marks, who's responsible for the FDA's oversight of cell and gene therapies, expects regulators around the world will be better at collaborating on gene …